Cargando…
Myocardial Infarction-Induced INSL6 Decrease Contributes to Breast Cancer Progression
Myocardial infarction (MI) induces early-stage breast cancer progression and increases breast cancer patients' mortality and morbidity. Insulin-like peptide 6 (INSL6) overexpression can impede cardiotoxin-induced injury through myofiber regeneration, playing a significant role in MI progression...
Autores principales: | Zheng, Yue, Gao, Wenqing, Wang, Song, Qi, Bingcai, Qi, Zhenchang, Hu, Xiaomin, Zhang, Qiang, Lang, Yuheng, Ning, Meng, Luo, Zhiqiang, Li, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928516/ https://www.ncbi.nlm.nih.gov/pubmed/36798786 http://dx.doi.org/10.1155/2023/8702914 |
Ejemplares similares
-
TSPAN4 and migrasomes in atherosclerosis regression correlated to myocardial infarction and pan-cancer progression
por: Zheng, Yue, et al.
Publicado: (2022) -
The Key Genes Underlying Pathophysiology Association between Plaque Instability and Progression of Myocardial Infarction
por: Zheng, Yue, et al.
Publicado: (2021) -
PIK3R1, SPNB2, and CRYAB as Potential Biomarkers for Patients with Diabetes and Developing Acute Myocardial Infarction
por: Zheng, Yue, et al.
Publicado: (2021) -
TSPAN4 is a prognostic and immune target in Glioblastoma multiforme
por: Zheng, Yue, et al.
Publicado: (2023) -
Macrophages-Related Genes Biomarkers in the Deterioration of Atherosclerosis
por: Zheng, Yue, et al.
Publicado: (2022)